Adams Expands OTC Cough Market Presence With Delsym Acquisition
This article was originally published in The Tan Sheet
Executive Summary
Adams Respiratory Therapeutics intends to aggressively promote Delsym cough suppressant to consumers following its May 24 acquisition of the brand